Metraipolis › archive › dc_5edc1a2da90f
Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques — Europe PMC PMID:40963596
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40963596
- DOI
- 10.3389/fimmu.2025.1630940
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:08:08.518Z
- SHA-256 of the archived text
275c1f589c38815428bdb5520e8431f5e4325d94420e47c697bc90194d8e020b- Stable URL of this page
https://metraipolis.com/documento/dc_5edc1a2da90f
How to cite
Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques — Europe PMC PMID:40963596 — Europe PMC (en), https://europepmc.org/article/MED/40963596 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5edc1a2da90f (Metraipolis archive dc_5edc1a2da90f, sha256 275c1f589c38815428bdb5520e8431f5e4325d94420e47c697bc90194d8e020b)
BibTeX
@misc{dc5edc1a2da90f,
title = {Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques — Europe PMC PMID:40963596},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40963596},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5edc1a2da90f; sha256 275c1f589c38815428bdb5520e8431f5e4325d94420e47c697bc90194d8e020b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963596. Agents can read the archived copy with the MCP tool read_document.